基石药业-B(02616):CS2009(PD-1/VEGF/CTLA-4三特异性抗体)II期临床试验申请获美国FDA批准
Last Update:
16 2 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.